Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
CURE New Issue Alert: Hematology Special Issue
Katie Kosko and Brielle Urciuoli
September is Blood Cancer Awareness month and
’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:
Socioeconomic Status May Affect Racial/Ethnic Disparities Among Childhood Cancer Survivors
Kristie L. Kahl
A recent study showed that socioeconomic status may explain racial and ethnic disparities found among childhood cancer survivors of certain cancers.
The Health Declaration: Is the Cancer Discussion Necessary?
Living a post-cancer lifestyle means including your medical history on a health declaration form and learning to deal with the consequences.
Taking a Shot to Treat Blood Cancers
Injectable forms of medication may benefit patients with blood cancers.
A Little of Everything: Exploring Strategies to Treat Non-Hodgkin Lymphoma
Targeted therapies, immunotherapies and combinations add new weapons to fight against non-Hodgkin lymphoma.
Expanding Access to Care Could Improve Follicular Lymphoma Outcomes
Kristie L. Kahl
A study published in
demonstrated the significant disparities found between insurance status and survival outcomes in patients of all ages with follicular lymphoma.
FDA Approves Drug Duo for Waldenstrom's Macroglobulinemia
Jason M. Broderick
The FDA has approved Imbruvica (ibrutinib) for use in combination with Rituxan (rituximab) as a treatment option across all lines of therapy for patients with Waldenström macroglobulinemia.
Dr. Jeff Young: From Practitioner to Patient
Dr. Jeff Young
In an interview with
, Young explained the importance of whole-person care that included aspects such as yoga and nutrition.
Patient Receives $289 Million in Landmark Monsanto-Associated Cancer Case
Dewayne Johnson, a patient with cancer who claimed that Monsanto’s Roundup product was at the root of his non-Hodgkin lymphoma diagnosis in 2014, was awarded $289 million by a jury, as reported by the Associated Press.
FDA Approves Drug for Rare Non-Hodgkin Lymphoma Types
A new treatment has been approved to treat two rare forms of non-Hodgkin lymphoma.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: